Related by context. All words. (Click for frequent words.) 77 RhuDex ® 74 IMA# 74 EndoTAG TM 73 Virulizin R 73 PSMA ADC 73 YONDELIS 72 EndoTAGTM 1 72 BAY #-# 71 vidofludimus 71 ELACYT 71 elotuzumab 71 enzastaurin 71 Sym# 71 PLK1 SNALP 71 Aplidin 71 Onconase 71 Bezielle 71 INCB# [001] 71 Archexin 71 pomalidomide 70 Panzem 70 ATL# [001] 70 lumiliximab 70 triphendiol 70 SNT MC# 70 EndoTAG 70 glufosfamide 70 ganetespib 70 CA4P 70 axitinib 70 Symadex 70 Phase IIIb clinical 70 MAGE A3 ASCI 70 AEG# 70 thymalfasin 70 PEG SN# 70 riociguat 70 HuMax CD# 70 goserelin 69 Traficet EN 69 PD LID 69 MEK inhibitor 69 nalbuphine ER 69 CIMZIA TM 69 DXL# 69 Bicifadine 69 HuLuc# 69 tesmilifene 69 phase IIa clinical 69 Aflibercept 69 Amrubicin 69 Virulizin ® 69 Proxinium TM 69 OHR/AVR# 69 Nanobody 69 Azedra 69 OXi# 69 UPLYSO 69 obatoclax 69 ularitide 69 Solazed 68 Cloretazine ® 68 sunitinib malate 68 EOquin TM 68 Phase IIb clinical trials 68 Dalbavancin 68 PSN# [002] 68 indibulin 68 phase IIb clinical 68 Xanafide 68 tafamidis 68 JAK inhibitor 68 WILEX 68 NXL# 68 Daclizumab 68 HuMax EGFr 68 Panzem R NCD 68 CBLC# 68 Factor VIIa 68 Nanobody ® 68 mapatumumab 68 Phase Ib study 68 masitinib 68 PROCHYMAL 68 Mipomersen 68 Tyrima 68 R#/MEM # 68 thetreatment 68 AQ4N 68 HGS# 68 ARIKACE ™ 68 phase IIa 68 PSN# [001] 68 SinuNase 68 registrational trial 68 RhuDex TM 68 EGS# 68 Desmoteplase 68 ASONEP 68 alvespimycin 68 Loramyc R 68 CD# antibody [001] 68 PRT# 68 tanespimycin 68 TELCYTA 68 Pertuzumab 68 Phase #b/#a clinical 68 Cloretazine 68 Nuvion 68 sapacitabine 68 Carfilzomib 68 HuMax CD4 68 Velcade bortezomib 68 KNS # 68 custirsen 68 deforolimus 68 forodesine 68 Allovectin 7 ® 67 TACI Ig 67 GRN# 67 Asentar 67 proteasome inhibitor 67 cannabinor 67 ONCONASE R 67 ApoB SNALP 67 IMC #B 67 talabostat 67 acyclovir Lauriad R 67 FluCide 67 Cloretazine R VNP#M 67 HGS ETR1 67 Cloretazine R 67 CIMZIA ™ 67 OncoVEX GM CSF 67 Civacir 67 Dacogen injection 67 Viramidine 67 favorable pharmacokinetic profile 67 phase IIb trial 67 pertuzumab 67 multicenter Phase II 67 HGS ETR2 67 elacytarabine 67 OMP #M# 67 ProSavin 67 GLPG# 67 registrational 67 mertansine 67 XmAb# 67 Neuradiab 67 Nexavar sorafenib 67 Golimumab 67 huC# DM4 67 TBC# 67 Allovectin 7 67 PDE4 inhibitor 67 Interferon alpha 67 preclinically 67 Alocrest 67 Aviptadil 67 Allovectin 7 R 67 trastuzumab DM1 67 SinuNase ™ 67 Nexavar ® 67 NV1FGF 67 seliciclib CYC# 67 atacicept 67 Phase #b/#a 67 Altastaph 67 CDK inhibitor 67 ACZ# 67 eniluracil 67 pegylated liposomal doxorubicin 67 Anavex #-# 67 oral prodrug 67 Fibrillex TM 67 vascular disrupting agent 67 Loramyc ® 67 Phase Ib II 67 Lu AA# 67 Temsirolimus 67 lomitapide 67 Phase Ib clinical 67 Phase 1a clinical 67 Reverset 67 Onco TCS 67 TG# [003] 67 NVA# 67 ThGRF 67 oral ridaforolimus 67 pradefovir 67 mGluR2 NAM 67 trabedersen 67 Solulin 67 zanolimumab 66 eltrombopag 66 Abiraterone acetate 66 investigational monoclonal antibody 66 huN# DM1 66 Azilect ® 66 OncoVEX 66 ONCONASE 66 talactoferrin 66 nucleoside analog 66 cilengitide 66 eprotirome 66 TMC# [002] 66 pan HDAC inhibitor 66 CCX# 66 DermaVir Patch 66 Fibrin Pad 66 otelixizumab 66 radiation sensitizer 66 sargramostim 66 neratinib 66 GFT# 66 liposomal formulation 66 Valdoxan 66 Phase Ib 66 Pirfenidone 66 Safinamide 66 ATL/TV# 66 adecatumumab 66 Pimavanserin 66 Synavive 66 RSD# oral 66 ALGRX 66 KRN# 66 receptor tyrosine kinase inhibitor 66 tolevamer 66 Ramoplanin 66 Pemetrexed 66 BAL# [002] 66 Guanilib 66 HCV protease inhibitor 66 JAK3 66 Intravenous CP 66 PEGylated 66 Trastuzumab 66 Phase IIB 66 GW# [003] 66 OncoGel 66 ridaforolimus 66 Actimmune ® 66 Tarceva TM 66 regorafenib 66 viral kinetics 66 MGd 66 NP2 Enkephalin 66 inhaled AAT 66 CGEN # 66 BiTE 66 Tarvacin TM 66 BRIM2 66 OvaRex R 66 HQK 66 TELINTRA 66 Omacetaxine 66 teriflunomide 66 SAR# [004] 66 clinical pharmacology studies 66 Panzem R 66 ixabepilone 66 TKM ApoB 66 budesonide foam 66 bardoxolone 66 phase IIb 66 Exelixis XL# 66 ENMD # 66 EFAPROXYN 66 Degarelix 66 Fulvestrant 66 Squalamine 66 TREANDA 66 isavuconazole 66 TRISENOX 66 Trofex 66 Tarvacin 66 tezampanel 66 Angiolix 66 CRMD# 66 CCX# B 66 antiangiogenic therapy 66 Tavocept 66 Neulasta ® 66 Alvesco R 66 Afatinib 66 EOquin 66 oral antiviral 66 Zybrestat 66 BNC# 66 Ocrelizumab 66 PDE# inhibitors 66 PXD# 66 Dacogen decitabine 66 Apoptone 66 ON #.Na 66 tumor necrosis 66 rilonacept 66 Aplidin R 66 fosbretabulin 66 decitabine 66 Locteron 66 midstage trials 66 Exherin TM 66 Fodosine 66 Phase IIb III 66 MediGene 66 investigational humanized monoclonal antibody 66 Icatibant 66 CEQ# 66 Rebif ® 66 DCCR 66 tocilizumab 66 ASA# 66 Phase 2a trial 66 personalized immunotherapy 66 MAXY G# 66 Vitaxin 66 ONTAK 66 ospemifene 66 therapeutic monoclonal antibody 66 lapatinib Tykerb 66 methylnaltrexone 66 Genasense ® 66 cytostatic 66 AeroLEF TM 66 darapladib 66 MYDICAR ® 66 Rezular 66 Quinamed 66 Aurexis 66 cytokine refractory 66 AZILECT ® 66 dirucotide 66 Phase IIa trials 66 Cethromycin 65 TRIOLEX 65 Microplasmin 65 MGCD# [001] 65 phase IIb III 65 CLORETAZINE TM VNP#M 65 IRX 2 65 TriRima 65 dacetuzumab 65 trastuzumab DM1 T DM1 65 NEUGENE 65 iniparib 65 Stimuvax R 65 Advexin 65 Octreotide 65 Vandetanib 65 TYZEKA 65 PLX cells 65 Telbivudine 65 DU #b 65 depsipeptide 65 ADAGIO study 65 renin inhibitors 65 brivaracetam 65 Lenocta 65 volociximab 65 orally bioavailable 65 LY# [003] 65 investigational therapies 65 ancrod 65 afatinib 65 Clolar ® 65 aflibercept 65 incyclinide 65 Orazol 65 Ozarelix 65 veltuzumab 65 RhuDex R 65 DAVANAT 65 Advagraf 65 metaglidasen 65 resminostat 65 Voreloxin 65 Aloxi injection 65 recombinant factor VIIa 65 CCR9 antagonist 65 Zalypsis 65 immatics 65 BEMA TM Fentanyl 65 temsirolimus 65 LHRH antagonist 65 SUTENT ® 65 VEGF Trap 65 crizotinib PF # 65 RhuDex 65 iroxanadine 65 TRO# 65 interferon gamma 1b 65 Zenvia ™ 65 entinostat 65 R roscovitine 65 Aptivus ® 65 sorafenib tablets 65 PROSTVAC TM 65 mRCC 65 Elocalcitol 65 CR# vcMMAE 65 CD# monoclonal antibody 65 corticosteroid dexamethasone 65 TOCOSOL Paclitaxel 65 ZACTIMA 65 FOLOTYN ® 65 ImmunoVEX HSV2 65 Rasagiline 65 SUTENT 65 L BLP# 65 anticancer compound 65 MOZOBIL 65 Insegia 65 tramiprosate Alzhemed TM 65 rindopepimut 65 iSONEP 65 IL# PE#QQR 65 thalidomide Thalomid 65 #D#C# 65 ToGA 65 evaluating tivozanib 65 canakinumab 65 MabCampath 65 NOX E# 65 velafermin 65 Panitumumab 65 omega interferon 65 Dasatinib 65 EZN 65 atrasentan 65 LEUKINE 65 SYN# 65 TheraCIM 65 PhG alpha 1 65 lintuzumab 65 CINTREDEKIN BESUDOTOX 65 targeting CD# 65 HCV protease inhibitors 65 bortezomib Velcade 65 Diamyd ® 65 E1 INT TM 65 TG# [001] 65 antiangiogenesis 65 pediatric acute lymphoblastic 65 XYOTAX TM 65 PI3K/Akt pathway inhibitor 65 bicifadine 65 orBec 65 Glypromate 65 Targretin 65 protein kinase inhibitor 65 C1 INH 65 Azedra ™ 65 APOPTONE 65 Cimzia TM 65 Seliciclib 65 Pyridorin 65 GLP toxicology studies 65 INTEGRILIN 65 Serdolect ® 65 tezampanel NGX# 65 BRAF inhibitor 65 pitavastatin 65 Phase #/#a trial 65 galiximab 65 Natalizumab 65 vosaroxin 65 SinuNase TM 65 Tamibarotene 65 Blinatumomab 65 Urocidin TM 65 vorinostat 65 Phase III randomized controlled 65 MYDICAR 65 Copegus ribavirin 65 targeted radiotherapeutic 65 OPAXIO 65 Enzastaurin 65 G#DT 65 M6G 65 ponatinib 65 CLARITY study 65 CRLX# 65 VNP#M 65 AMD# [003] 65 oxaliplatin Eloxatin 65 Cetrorelix 65 INTERCEPT platelets 65 Decitabine 65 GV# [001] 65 Tanespimycin 65 Talotrexin 65 Azedra TM 65 UVIDEM 65 Taxotere ® 65 Plicera 65 Relivar 65 PCK# 65 relapsed MM 65 CytoFabTM 65 glucokinase activator 65 Anticalin ® 65 sorafenib Nexavar 65 relapsed multiple myeloma 65 PKC# 65 GAP #B# 65 Removab 65 generation purine nucleoside 65 Fludara 65 amrubicin 65 Telatinib 65 CYT# potent vascular disrupting 64 CIMZIA TM certolizumab pegol 64 Epratuzumab 64 MAXY VII 64 Onrigin 64 radezolid 64 herpetic keratitis 64 Aurora kinase 64 dextromethorphan quinidine 64 ProLindac 64 Shigamabs ® 64 DDP# 64 oral fludarabine 64 PROMACTA 64 delafloxacin 64 HCD# [002] 64 Cimzia ® certolizumab pegol 64 Doxil ® 64 Vicinium TM 64 rFVIIIFc 64 Chrysalin 64 preclinical efficacy 64 ZOLINZA 64 ofatumumab 64 CoFactor 64 TLK# 64 ganaxolone 64 YONDELIS R 64 Octreolin 64 Amplimexon 64 valopicitabine 64 MyVax R 64 estramustine 64 PEGPH# 64 castrate resistant prostate cancer 64 BiTE antibody 64 ATL# [002] 64 orally administered inhibitor 64 Hepatocellular Carcinoma HCC 64 IV Busulfex 64 anti angiogenic therapy 64 gefitinib Iressa 64 Uvidem 64 initiate Phase 1b 64 lenalidomide Revlimid R 64 HspE7 64 CA9 SCAN 64 paclitaxel Taxol ® 64 acyclovir Lauriad ® 64 ZYBRESTAT fosbretabulin 64 pharmacokinetic PK study 64 lorvotuzumab mertansine 64 nonclinical studies 64 cancer immunotherapies 64 subcutaneous PRO 64 Ceflatonin 64 TH# [003] 64 seliciclib 64 immunomodulatory 64 Epanova 64 Annamycin 64 noninfectious uveitis 64 vascular disrupting agents 64 Specifid 64 glatiramer 64 Ketotransdel 64 nanoviricides 64 IMC A# 64 Thiovir 64 HyACT 64 outlicensing 64 phase IIb study 64 anticancer agent 64 Thrombin 64 Interferon beta 64 Dapagliflozin 64 cathepsin K inhibitor 64 antiangiogenic 64 PROSTVAC VF 64 danoprevir 64 phase Ib 64 BZL# 64 MAP# 64 celgosivir 64 Dextofisopam 64 low dose cytarabine 64 ORENCIA R 64 Personalized Immunotherapy 64 docetaxel Taxotere ® 64 tramiprosate ALZHEMED TM 64 Varespladib 64 OvaRex ® MAb 64 Cethrin 64 CTAP# Capsules 64 Bortezomib 64 GMX# 64 Ixempra 64 #ME# 64 Phase IIb trials 64 paclitaxel poliglumex 64 GSK# [001] 64 telaprevir VX 64 Nanobodies ® 64 Leukine 64 gemcitabine Gemzar ® 64 Curaxin 64 leading oral taxane 64 angiogenesis inhibitor 64 Gemzar ® 64 NEUMUNE 64 trabectedin 64 DACH platinum 64 nanoviricide drug 64 mTOR inhibition 64 cediranib 64 Naproxcinod 64 ELND# 64 tubulin inhibitor 64 Elesclomol 64 romidepsin 64 REP# 64 Corlux 64 Talabostat 64 anti EGFR antibody 64 Davanat 64 AZILECT R 64 dose escalation phase 64 lenalidomide dexamethasone 64 CYC# 64 XL# [003] 64 DeveloGen 64 ocrelizumab 64 Ophena TM 64 APTIVUS 64 trial evaluating PRX# 64 IFN α 64 Gleevec resistant 64 immunomodulation 64 LUX Lung 64 CANCIDAS 64 Deforolimus 64 Imprime PGG 64 evaluating satraplatin 64 Pruvel 64 Urocidin 64 Androxal TM 64 ICA # 64 IAP inhibitor 64 GRNVAC1 64 Gemcitabine 64 molecularly targeted 64 LymphoStat B belimumab 64 durable remissions 64 randomized Phase 2b 64 ACOMPLIA R 64 NS#/#A protease 64 IMGN# 64 MT# MEDI 64 NOXXON 64 Vidofludimus 64 isoform selective 64 oral methylnaltrexone 64 rALLy clinical trial 64 Phase IIa trial 64 TEMODAL 64 CaPre TM 64 StemEx 64 refractory AML 64 Alzhemed TM 64 baminercept 64 Onalta ™ 64 Triapine R 64 Clavis Pharma 64 virus HCV protease inhibitor 64 immune modulatory 64 Genz # 64 Granulocyte Colony Stimulating Factor 64 ulimorelin 64 AVE# 64 Ostarine 64 multiple myeloma MM 64 midstage clinical 64 ALN PCS 64 demonstrated antitumor activity 64 BCR ABL inhibitors 64 faropenem 64 StemEx R 64 Litx 64 Angiocept 64 urocortin 2 64 Tasimelteon 64 JAK Inhibitor 64 tyrosine kinase inhibitor 64 receptor inhibitor 64 TroVax ® 64 LT NS# 64 therapeutic monoclonal antibodies 64 Santhera 64 docetaxel chemotherapy 64 Arcalyst 64 Vernakalant 64 LymphoStat B 64 Marqibo TM 64 RECOTHROM R 64 GAMMAGARD 64 MDV# 64 ALN TTR# 64 Pazopanib 64 relapsed ovarian cancer 64 pharmacokinetic interactions 64 LHRH antagonists 64 Cytolin R 64 BioNumerik 64 Actimmune R 64 ANYARA 64 randomized controlled Phase 64 RPL# 64 PRX# 64 Pradefovir 64 diabetic neuropathic pain 64 NPC 1C 64 Gabapentin GR 64 LHRH agonists 63 Phase 1b clinical trials 63 Elafin 63 ara C 63 rHuPH# 63 CCR5 antagonist 63 Lupuzor 63 nucleoside analogues 63 Menerba 63 oral salmon calcitonin 63 selective modulator 63 solithromycin 63 T#I [002] 63 synthetic retinoid 63 RAPTIVA 63 ALN TTR 63 FTY# 63 Azacitidine 63 Hycamtin 63 AP# [003] 63 cMET 63 photoprotective drug 63 Irinotecan 63 ISIS # 63 GSK# [002] 63 Evoltra 63 PEG interferon 63 Tesetaxel 63 Zemplar Capsules 63 SUCCEED trial 63 Amigal 63 nab paclitaxel 63 etanercept Enbrel 63 BrachySil TM 63 sJIA 63 Elagolix 63 Arikace 63 oropharyngeal candidiasis 63 PORxin TM 63 GLYX 63 CRD5 63 prucalopride 63 budiodarone 63 Solazed TM 63 ISTODAX 63 zileuton 63 APTIVUS r 63 Perifosine 63 AA Amyloidosis 63 Onrigin TM 63 tranilast 63 Firazyr 63 RGB # 63 milatuzumab 63 CDP# 63 ocular formulation 63 reslizumab 63 Fx #A 63 BRIM3 63 novel anticancer 63 Anticalin 63 Glufosfamide 63 SCCHN 63 PLX# 63 DOS# 63 teduglutide 63 GALNS 63 PrevOnco 63 PHX# 63 HER2 positive metastatic breast 63 chimeric monoclonal antibody 63 MBP# [001] 63 Azixa 63 IMP# 63 antiangiogenic agents 63 Apixaban 63 Veronate 63 histamine dihydrochloride 63 omacetaxine mepesuccinate 63 Zolinza 63 immunomodulator 63 PEP# [003] 63 refractory acute myeloid 63 Bendamustine 63 epothilone 63 Ceflatonin R 63 epratuzumab 63 TORISEL 63 rNAPc2 63 pivotal bioequivalence 63 R sorafenib tablets 63 Telintra 63 sitaxsentan 63 recurrent glioblastoma multiforme 63 Phenoptin 63 Romidepsin 63 BLA filing 63 Cleviprex TM clevidipine 63 Theratope 63 cleavable linker 63 retapamulin 63 beta 1a 63 Oasmia 63 ZADAXIN ® 63 Mycamine 63 Tesmilifene 63 Vilazodone 63 phosphatidylserine PS targeting 63 Posiphen 63 Alpharadin 63 mifamurtide 63 anidulafungin 63 Eligard ® 63 Aliskiren 63 RIGScan CR 63 adipiplon 63 oral FTY# 63 Gleevec Glivec 63 JAK2 inhibitor 63 biliary tract cancer 63 iclaprim 63 epigenetic therapies 63 standard chemotherapy regimen 63 metastatic castration resistant 63 antibody MT# 63 BIBW 63 immunotoxin 63 CD# CEA 63 Xerecept 63 Roche Xeloda 63 omacetaxine 63 AERx iDMS 63 palonosetron 63 Campath ® 63 Chemokine 63 epothilones 63 Trofex TM 63 Ambrisentan 63 Saforis 63 ARIKACE 63 Protexia ® 63 Catena ® 63 tigecycline 63 Triolex 63 Vicriviroc 63 DCVax ® 63 XL# XL# 63 midstage studies 63 dexanabinol 63 vismodegib 63 novel VDA molecule 63 Cx# [002] 63 MAb 63 Rituximab 63 PGL# 63 CD3 monoclonal antibody 63 Kevetrin 63 MKC# MT 63 elvucitabine 63 nitric oxide donating prostaglandin 63 busulfan 63 bendamustine 63 BLA submission 63 mTOR inhibitors 63 lupus nephritis 63 Gleevec imatinib mesylate 63 Mepact 63 voclosporin 63 histone deacetylase HDAC inhibitor 63 cytoprotective 63 Acute Radiation Syndrome ARS 63 humanized monoclonal antibody 63 zalutumumab 63 Romiplostim 63 Sapacitabine 63 Spiegelmer ® 63 oral rivaroxaban 63 drug conjugate 63 oblimersen 63 vemurafenib 63 Xeloda ® 63 ACAPODENE 63 malignant ascites 63 davunetide intranasal AL 63 erlotinib Tarceva ® 63 dose escalation Phase 63 metastatic hormone refractory 63 aclidinium bromide 63 ozarelix 63 aleglitazar 63 JAK3 inhibitor 63 Toraymyxin TM 63 metastatic renal cell 63 DPX Survivac 63 Restanza 63 OMAPRO 63 pharmacokinetic characteristics 63 INT# [002] 63 Akt inhibitor 63 Æterna Zentaris 63 microtubule inhibitor 63 Prodarsan ® 63 IND submission 63 rhThrombin 63 LUMINATE 63 Nanobodies 63 Xelox 63 torezolid phosphate 63 Elotuzumab 63 rxRNA 63 Anticalin R 63 XOMA 3AB 63 fostamatinib 63 GVAX 63 Huntexil 63 STRIDE PD 63 Ixabepilone 63 PREOS R 63 recurrent GBM 63 inhibitor RG# 63 tramiprosate 63 dose escalation clinical 63 BCX# 63 Anticalins ® 63 Yondelis ® 63 visilizumab 63 xenograft models 63 Tarceva erlotinib 63 cetuximab Erbitux 63 multicenter randomized placebo controlled 63 Oglemilast 63 Radilex 63 Phase #/#a 63 PrevOnco ™ 63 SERMs 63 Syncria 63 Gastrointestinal Stromal Tumors 63 MoxDuo IR 63 MyVax 63 THALOMID 63 AKT inhibitor 63 plasma kallikrein inhibitor 63 posaconazole 63 ChronVac C ® 63 metastatic RCC 63 EXPAREL TM 63 IMiDs R 63 bafetinib 63 oral picoplatin 63 Proellex TM 63 Capesaris 63 Bafetinib 63 ATPace TM 63 Anidulafungin 63 Meets Primary Endpoint 63 Cardio Vascu Grow 63 oxidative stress inducer 63 PF # [002] 63 miconazole Lauriad ® 63 hA# 63 LymphoStat B TM 63 Interferon Beta 63 AEGR 63 MEK inhibitor RDEA#